KAKEN PHARMACEUTICAL

kaken-pharmaceutical-logo

Kaken Pharmaceutical is a specialty pharmaceutical company that develops and commercializes novel pharmaceuticals and medical devices.

#SimilarOrganizations #People #Financial #More

KAKEN PHARMACEUTICAL

Social Links:

Industry:
Health Care Manufacturing Medical Device Pharmaceutical

Founded:
1948-03-01

Status:
Active

Contact:
81-3-5977-5002

Technology used in webpage:
Apple Mobile Web Clips Icon Apache Apache 2.4 OpenSSL GlobalSign GlobalSign Domain Verification Red Hat Enterprise Linux Internap


Similar Organizations

jaber-ibn-hayyan-pharmaceutical-logo

Jaber Ibn Hayyan Pharmaceutical

Jaber Ibn Hayyan Pharmaceutical manufactures drugs like anti-biotic, non-antibiotic , topical, oral and others.

kilitch-drugs-logo

Kilitch Drugs

Kilitch Drugs is a Pharma Company that provides like Parenteral solutions, Effervescent, Nutritional Products & Medical devices.

merck-logo

Merck

Merck is a pharmaceutical and chemical enterprise that develops prescription drugs and over-the-counter products.

synmosa-biopharma-logo

Synmosa Biopharma

Synmosa is a specialty pharmaceutical corporation that engages in diversified development that includes acting as an agent, manufacturing.

well-pharmaceutical-logo

Well Pharmaceutical

Well Pharmaceutical is a supplier of pharmaceutical excipients and high-end lubricant base oils and special surfactants.

zhejiang-jingxin-pharmaceutical-logo

Zhejiang Jingxin Pharmaceutical

Zhejiang Jingxin Pharmaceutical is a listed pharmaceutical company integrating R&D, production and sales.

Current Employees Featured

not_available_image

Hiroyuki Horiuchi
Hiroyuki Horiuchi CEO, President and Director @ Kaken Pharmaceutical
CEO, President and Director
2020-01-01

Stock Details


Company's stock symbol is TYO:4521

Acquisitions List

Date Company Article Price
2021-11-30 ARTham Therapeutics ARTham Therapeutics acquired by Kaken Pharmaceutical 5.5 B JPY

Investments List

Date Company Article Money raised
2021-01-29 GENEX Kaken Pharmaceutical investment in Seed Round - GENEX N/A

More informations about "Kaken Pharmaceutical"

KAKEN at a Glance | KAKEN PHARMACEUTICAL CO., LTD.

Kaken Pharmaceutical (KAKEN) is an R&D-driven pharmaceutical company that was established after the reorganization of the Institute of Physical and Chemical Research (Riken) in 1948. To โ€ฆSee details»

KAKEN PHARMACEUTICAL CO., LTD. | Member Companies | Japan ...

This page is a KAKEN PHARMACEUTICAL CO., LTD. page of JPMA. Address: 2-28-8 Honkomagome, Bunkyo-ku, Tokyo 113-8650. Contact: Phone๏ผš+81-3-5977-5046See details»

KAKEN Pharmaceutical Co., Ltd. - eu-japan.eu

2 BUSINESS DEVELOPMENT Medical Device 10.9% Agro-veterinary 5.5% Pharmaceuticals 78.8% Others 4.8% Head Office๏ผšTokyo, Japan Founded: March 1, 1948 Employees: 1,397 โ€ฆSee details»

Organization | Kaken Pharmaceutical Co.,Ltd.

Kaken Pharmaceutical Co.,Ltd. Report issue For profit Phase 2 Phase 3 Founded: Tokyo Japan (1948)See details»

Kaken Pharmaceutical Company Description - Stock Analysis

Aug 28, 2023 The company offers pharmaceutical products and medical devices, such as Clenafin, a topical treatment for onychomycosis; Artz, an anti-osteoarthritis agent; Fiblast, a โ€ฆSee details»

About KAKEN | KAKEN PHARMACEUTICAL CO., LTD.

About KAKEN of Kaken Pharmaceutical Co.,Ltd.See details»

Johnson & Johnson, Kaken Pharmaceutical Strike Licensing โ€ฆ

Jan 3, 2025 Additionally, Kaken will be eligible to receive an equity investment from Johnson & Johnson Innovationโ€”JJDC, Inc.โ€”the venture capital organization of Johnson & Johnson. 1. โ€ฆSee details»

Management Team | KAKEN โ€ฆ

Director, Pharmaceutical Common Achievement Tests Organization (to present) Oct. 2018: Board Member, Japan Society for Pharmaceutical Education (to present) Apr. 2023: โ€ฆSee details»

Kaken Pharmaceutical - Crunchbase Investor Profile

Kaken Pharmaceutical produces and supplies agrochemicals, feed additives, and veterinary drugs. They also offer pesticides such as horticultural fungicide, lawn fungicide, acaricide, box application agents for paddy rice, temacat โ€ฆSee details»

Johnson & Johnson to license novel oral assets, further โ€ฆ

Dec 26, 2024 The Company is licensing a STAT6 program from Kaken Pharmaceutical that targets a clinically relevant pathway in atopic dermatitis as well as other autoimmune and โ€ฆSee details»

JnJ enters licensing agreement for global development, โ€ฆ

Dec 27, 2024 Kaken will retain the commercialization rights in Japan, where Johnson & Johnson will have an option to enter into a co-promotion agreement with Kaken. Separately, Kaken is โ€ฆSee details»

Mission Statement, Vision, & Core Values (2024) of Kaken โ€ฆ

[relinking] Home Overview Mission Vision Values An Overview of Kaken Pharmaceutical Co., Ltd.General Summary of Kaken Pharmaceutical Co., Ltd. Kaken Pharmaceutical Co., Ltd. was โ€ฆSee details»

J&J Bags Kakenโ€™s STAT6 Inhibitor, Set to Take 6% Stake in Japan Firm

Dec 26, 2024 Kaken Pharmaceutical said on December 26 that it is out-licensing its STAT6 program, including the preclinical oral agent KP-723 for Type 2 inflammatory diseases, to โ€ฆSee details»

Kaken Pharmaceutical - Craft

Oct 29, 2024 Kaken Pharmaceutical is a company focusing on the development and commercialization of pharmaceuticals and medical devices in the orthopedics and โ€ฆSee details»

STAT6 inhibitors (Kaken) - Drug Targets, Indications, Patents

Dec 5, 2024 We tested three bilaterally established lung cancer murine models: Lewis lung carcinoma in B6.Foxp3 EGFP mice, and 344SQ-parental or 344SQ anti-PD1-resistant โ€ฆSee details»

Operational excellence in biopharma research and early โ€ฆ

1 day ago Organizations can accelerate research and early development by systematically mapping key processes such as pharmaceutical sciences, research, writing, and regulatory โ€ฆSee details»

Development Pipeline | KAKEN PHARMACEUTICAL CO., LTD.

May 14, 2024 Development Pipeline of Kaken Pharmaceutical Co.,Ltd. Development Code Planned Indication Development Stage Notes; KAR: Head lice: Phase โ…ขSee details»

Pharmaceuticals Business | KAKEN PHARMACEUTICAL CO., LTD.

Pharmaceuticals Business of Kaken Pharmaceutical Co.,Ltd. Message from the President. Long-Term Business PlanSee details»

Investor Relations | KAKEN PHARMACEUTICAL CO., LTD.

Investor Relations of Kaken Pharmaceutical Co.,Ltd. Message from the President. Long-Term Business PlanSee details»

linkstock.net © 2022. All rights reserved